ADVANCING BACTERIOPHAGE SCIENCE
WE ARE THE TRUSTED EXPERTS
EXCELLENCE IN
BACTERIOPHAGE PRODUCTION
The global threat of antibiotic-resistant infections demands innovative solutions. With an estimated 700,000 annual deaths and projections of 10 million by 2050, the need for alternative treatments is critical. Bacteriophages offer promising potential, but their production faces significant challenges in meeting regulatory standards and scaling to meet global demand.
Qeen stands at the forefront of this critical field, addressing the urgent need for high-quality bacteriophage manufacturing. As a center of excellence, we drive innovation in biomanufacturing, developing advanced delivery systems for bacteriophages. Our initiative-based approach tackles complex challenges, serving diverse industries including life sciences, pharmaceuticals, agriculture, and veterinary medicine.
With the current new antibiotic market failing to meet growing needs, non-traditional antibacterials like bacteriophages are rapidly gaining importance. However, there’s a severe shortage of third-party providers capable of producing bacteriophages at a world-class level while meeting stringent regulatory requirements. Qeen fills this crucial gap, offering expertise in formulation development and related analytical capabilities to advance the field of bacteriophage therapy.
Focusing Your Mind, with The
Best Expert.
